User:Y-S.Ko/Wikipedia course/Medical/Digestive
Preclinical
editAnatomy of the gastrointestinal tract, excluding the mouth | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper |
| ||||||||||||||||||||
| Lower |
| ||||||||||||||||||||
| Wall | |||||||||||||||||||||
Anatomy of the liver, pancreas and biliary tree | |||||
|---|---|---|---|---|---|
| Liver | |||||
| Biliary tract |
| ||||
| Pancreas |
| ||||
Physiology of the gastrointestinal system | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GI tract |
| ||||||||||||||||||||||||||||||||
| Accessory |
| ||||||||||||||||||||||||||||||||
| Abdominopelvic | |||||||||||||||||||||||||||||||||
Clinical
edit| Gastrointestinal tract | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Accessory | |||||||||
| Defecation | |||||||||
| Abdomen |
| ||||||||
| Hernia | |||||||||
| Other | |||||||||
Diseases of the human digestive system | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper GI tract |
| ||||||||||
| Lower GI tract Enteropathy |
| ||||||||||
| GI bleeding | |||||||||||
| Accessory |
| ||||||||||
| Other |
| ||||||||||
Drugs
editStomatological preparations (A01) | |
|---|---|
| Caries prophylaxis | |
| Infection and antiseptics |
|
| Corticosteroids (Glucocorticoids) | |
| Other | |
| Magnesium (increases motility) | |
|---|---|
| Aluminium (decreases motility) | |
| Calcium | |
| Sodium | |
| Combinations and complexes of aluminium, calcium and magnesium | |
| H2 antagonists ("-tidine") | |
|---|---|
| Prostaglandins (E)/ analogues ("-prost-") | |
| Proton-pump inhibitors ("-prazole") | |
| Potassium-competitive acid blockers ("-prazan") | |
| Others | |
| Combinations | |
| |
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
| ||||||||||||
| Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
| Propulsives | |||||||||||||
| 5-HT3 serotonin ion channel antagonists | |
|---|---|
| 5-HT serotonin G-protein receptor antagonists | |
| CB1 agonists (cannabinoids) | |
| D2/D3 antagonists | |
| H1 antagonists (antihistamines) | |
| mACh antagonists (anticholinergics) |
|
| NK1 antagonists | |
| Others | |
| Stool softeners | |
|---|---|
| Stimulant laxatives | |
| Bulk-forming laxatives | |
| Lubricant laxatives | |
| Osmotic laxatives | |
| Enemas | |
| Opioid antagonists | |
| Others | |
| Rehydration | |
|---|---|
| Intestinal anti-infectives | |
| Intestinal adsorbents |
|
| Antipropulsives (opioids) |
|
| Intestinal anti-inflammatory agents |
|
| Antidiarrheal micro-organisms | |
| Other antidiarrheals | |
| |
| Stimulants |
| ||||||
|---|---|---|---|---|---|---|---|
| Cannabinoid antagonists | |||||||
| GLP-1, GIP, and / or glucagon agonists | |||||||
| DACRAs | |||||||
| 5-HT2C receptor agonists | |||||||
| Absorption inhibitors | |||||||
| Uncouplers | |||||||
| Others | |||||||
| |||||||